Cyclo Therapeutics (CYTH) Reports Positive Outcome from Type C Meeting with the U.S. FDA Discussing Trappsol Cyclo streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Ongoing pivotal Phase 3 study evaluating Trappsol® Cyclo™ for the treatment of Niemann-Pick Disease Type C1
FDA feedback provides direction for the comparative interim analysis
With aligned.
Cyclo Therapeutics Receives IND Clearance from the U.S. FDA to Advance its Phase 2 Study of Trappsol Cyclo for the Treatment of Alzheimers Disease financialbuzz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialbuzz.com Daily Mail and Mail on Sunday newspapers.